Skip to main content


Fig. 3 | BMC Cancer

Fig. 3

From: PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes

Fig. 3

Kaplan-Meier plots in Luminal-B subtype. Kaplan-Meier estimates of DFS, LRFS and DRFS in patients with Luminal-B tumours (n = 176), according to high (solid green lines) and low (dashed blue lines) expression of PLCγ1, PLCγ1-pY1253 and PLCγ1-pY783. In this cohort, the patients showed distant relapse in 15% (12/81) PLCγ1Low and 24% (23/95) PLCγ1High, in 13% (13/100) PLCγ1-pY1253Low and 29% (22/76) PLCγ1-pY1253High, and in 19% (27/140) PLCγ1-pY783Low and 22% (8/36) PLCγ1-pY783High

Back to article page